+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Leptomeningeal Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Leptomeningeal Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Neurofibromatosis Type 2 - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibromatosis Type 2 - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Digital Marketing Trends in Severe Asthma - Product Thumbnail Image

Digital Marketing Trends in Severe Asthma

  • Report
  • August 2022
  • 35 Pages
  • Global
From
Biotech Ingredient Global Market Report 2024 - Product Thumbnail Image

Biotech Ingredient Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Smart Life Sciences Manufacturing Global Market Report 2024 - Product Thumbnail Image

Smart Life Sciences Manufacturing Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Digital Marketing Trends in Breast Cancer - Product Thumbnail Image

Digital Marketing Trends in Breast Cancer

  • Report
  • November 2022
  • 34 Pages
  • Global
From
Adrenocortical Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Adrenocortical Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
OX-40 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

OX-40 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Loading Indicator